Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-21

FDA Approved: FINZALA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for FINZALA, a combined oral contraceptive containing norethindrone acetate, ethinyl estradiol, and ferrous fumarate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FINZALA (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)

Snippet

SUPPL AP for FINZALA (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)